Related Experiment Video
Updated: Jan 8, 2026

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.6K
Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review
Matthew B Bratton1, Humza A Pirzadah1, Michael J Starns1
1School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Current Pain and Headache Reports
|December 15, 2025
Summary
Periosteal osteosarcomas are rare bone cancers. Treatment strategies are not well-defined, but pain management and molecular targets like the p53 gene show promise for future research.
Area of Science:
- Orthopedic Oncology
- Bone Malignancies
- Skeletal Tumors
Background:
- Periosteal osteosarcomas are rare, accounting for <2% of bone malignancies.
- Previously thought to affect long bone diaphysis, now found in clavicle, mandible, and scapula.
- Limited data exists on optimal treatment strategies.
Purpose of the Study:
- Synthesize current data on periosteal osteosarcomas.
- Examine clinical, histologic, and radiographic presentations.
- Investigate potential biomarkers and recommend future research directions.
Main Methods:
- Literature review and synthesis of existing data.
- Analysis of clinical presentations, including pain management.
- Review of molecular findings and potential therapeutic targets.
Main Results:
- Survival and recurrence are influenced by stage, grade, and medullary invasion.
- Bone pain is a common symptom, managed with opioids and adjuvant drugs.
- Common mutations, like p53 gene, identified, suggesting future molecular targets.
Conclusions:
- Further research is needed to establish optimal treatment protocols.
- Biomarker discovery is crucial for targeted therapies.
- Understanding molecular alterations may guide future periosteal osteosarcoma management.
Related Concept Videos
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Barrett Esophagus-II: Clinical Manifestations and Management
738
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
738
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K

